The high expression of miR-31 in lung adenocarcinoma inhibits the malignancy of lung adenocarcinoma tumor stem cells

被引:5
|
作者
Xu, Ran [3 ]
Liu, Tianhua [1 ]
Zuo, Ling [2 ]
Guo, Dongqing [2 ]
Ye, Guancheng [1 ]
Jiang, Jingjing [4 ]
Yu, Xue [1 ]
Zhang, Shujing [1 ]
Hou, Chunying [1 ]
机构
[1] Beijing Univ Chinese Med, Sch Tradit Chinese Med, Beijing, Peoples R China
[2] Beijing Univ Chinese Med, Sch Life Sci, Beijing, Peoples R China
[3] Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing, Peoples R China
[4] Beijing Univ Chinese Med, Sch Humanities, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
MiR-31; LUAD; CSCs; Tumorigenesis; Metastasis; DRUG-RESISTANCE; CANCER; MICRORNA-31;
D O I
10.1016/j.bbrep.2021.101122
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Therapies for lung adenocarcinoma (LUAD) are mainly limited by drug resistance, metastasis or recurrence related to cancer stem cells (CSCs) with high proliferation and self-renewing. This research validated that miR-31 was over-expressed in LUAD by the analysis of generous clinical samples data. And the results of clinical data analysis showed that high expression of miR-31 was more common in patients with worse prognosis. The genes differentially expressed in LUAD tissues compared with normal tissues and A549CD133(+) cells (LUAD CSCs) compared with A549 cells were separately screened from Gene Expression Profiling Interactive Analysis and GEO datasets. The target genes that may play a role in the regulation of lung adenocarcinoma was screened by comparison between the differential genes and the target genes of miR-31. The functional enrichment analysis of GO Biological Processes showed that the expression of target genes related to cell proliferation was increased, while the expression of target genes related to cell invasion and metastasis was decreased in LUAD tissues and A549CD133(+) cells. The results suggested that miR-31 may have a significant inhibitory effect on the differentiation, invasion, metastasis and adhesion of LUAD CSCs, which was verified in vivo and in vitro experiments. Knock down of miR-31 accelerated xenograft tumor growth and liver metastasis in vivo. Likewise, the carcinogenicity, invasion and metastasis of A549CD133(+) CSCs were promoted after miR-31 knockdown. The study validated that miR-31 was up regulated in LUAD and its expression may affect the survival time of patients with lung adenocarcinoma, which indicated that miR-31 may have potential value for diagnosis and prognosis of LUAD. However, the inhibitory effect of miR-31 on tumorigenesis, invasion and metastasis of lung adenocarcinoma CSCs suggested its complexity in the regulation of lung adenocarcinoma, which may be related to its extensive regulation of various target genes.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Semaphorin 6A inhibits the cell migration in lung adenocarcinoma cells
    Shen Cheng-Ying
    Li Yung-Hua
    Lu Tzu-Pin
    Lai Liang-Chuan
    Eric, Chuang Y.
    Tsai Mong-Hsun
    CANCER RESEARCH, 2011, 71
  • [32] Blocking transferrin receptor inhibits the growth of lung adenocarcinoma cells in vitro
    Wu, Yihe
    Xu, Jinming
    Chen, Jinbo
    Zou, Meirong
    Rusidanmu, Aizemaiti
    Yang, Rong
    THORACIC CANCER, 2018, 9 (02) : 253 - 261
  • [33] MIR99AHG is a noncoding tumor suppressor gene in lung adenocarcinoma
    Han, Chencheng
    Li, Hong
    Ma, Zhifei
    Dong, Guozhang
    Wang, Qianyun
    Wang, Siwei
    Fang, Panqi
    Li, Xiang
    Chen, Hao
    Liu, Tongyan
    Xu, Lin
    Wang, Jie
    Wang, Jun
    Yin, Rong
    CELL DEATH & DISEASE, 2021, 12 (05)
  • [34] MIR99AHG is a noncoding tumor suppressor gene in lung adenocarcinoma
    Chencheng Han
    Hong Li
    Zhifei Ma
    Guozhang Dong
    Qianyun Wang
    Siwei Wang
    Panqi Fang
    Xiang Li
    Hao Chen
    Tongyan Liu
    Lin Xu
    Jie Wang
    Jun Wang
    Rong Yin
    Cell Death & Disease, 12
  • [35] Warranting Investigation of Primary Lung Adenocarcinoma in Patients With an Extrapulmonary Malignancy and Lung Nodules Due to High Frequency
    Zhu, Bing
    Dalal, Shavari
    Kamp, David W.
    Lin, Xiaoqi
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2014, 141 (03) : 429 - 436
  • [36] Diversity of gene expression in adenocarcinoma of the lung
    Garber, ME
    Troyanskaya, OG
    Schluens, K
    Petersen, S
    Thaesler, Z
    Pacyna-Gengelbach, M
    van de Rijn, M
    Rosen, GD
    Perou, CM
    Whyte, RI
    Altman, RB
    Brown, PO
    Botstein, D
    Petersen, I
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) : 13784 - 13789
  • [37] Selenium requirements for expression of GPxs in human lung adenocarcinoma cells
    Romanowska, M
    Kikawa, KD
    Fields, JR
    Anderson, LM
    FASEB JOURNAL, 2006, 20 (04): : A146 - A147
  • [38] Gene expression profiling of cancer stem cell in human lung adenocarcinoma A549 cells
    Seo, Dong-Cheol
    Sung, Ji-Min
    Cho, Hee-Jung
    Yi, Hee
    Seo, Kun-Ho
    Choi, In-Soo
    Kim, Dong-Ku
    Kim, Jin-Suk
    Am, Abd El-Aty
    Shin, Ho-Chul
    MOLECULAR CANCER, 2007, 6 (1)
  • [39] Expression and role of FKBPL in lung adenocarcinoma
    She, Lili
    Zhang, Xingsong
    Shen, Rong
    He, Song
    Miao, Xiaobing
    JOURNAL OF CANCER, 2024, 15 (01): : 166 - 175
  • [40] Quantification of protein Z expression in lung adenocarcinoma tissues and cells
    Wang, Hong
    Huang, Fang
    Pan, Xue-Yi
    Guan, Ze-Bin
    Zeng, Wen-Bing
    Li, Ming-Jie
    Zhang, Rui-Hao
    SPRINGERPLUS, 2016, 5